Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mrs K Sturt 21/03/2023 Mr N Sturt 21/03/2023 29 July 2025 no description of principal activity 14746087 2025-03-31 14746087 bus:Director1 2025-03-31 14746087 bus:Director2 2025-03-31 14746087 2024-03-31 14746087 core:CurrentFinancialInstruments 2025-03-31 14746087 core:CurrentFinancialInstruments 2024-03-31 14746087 core:ShareCapital 2025-03-31 14746087 core:ShareCapital 2024-03-31 14746087 core:RetainedEarningsAccumulatedLosses 2025-03-31 14746087 core:RetainedEarningsAccumulatedLosses 2024-03-31 14746087 core:FurnitureFittings 2024-03-31 14746087 core:FurnitureFittings 2025-03-31 14746087 2024-04-01 2025-03-31 14746087 bus:FilletedAccounts 2024-04-01 2025-03-31 14746087 bus:SmallEntities 2024-04-01 2025-03-31 14746087 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14746087 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14746087 bus:Director1 2024-04-01 2025-03-31 14746087 bus:Director2 2024-04-01 2025-03-31 14746087 core:FurnitureFittings core:TopRangeValue 2024-04-01 2025-03-31 14746087 2023-04-01 2024-03-31 14746087 core:FurnitureFittings 2024-04-01 2025-03-31 14746087 core:CurrentFinancialInstruments 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 14746087 (England and Wales)

HIJK MEDICAL SERVICES LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

HIJK MEDICAL SERVICES LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

HIJK MEDICAL SERVICES LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
HIJK MEDICAL SERVICES LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 244 306
244 306
Current assets
Debtors 4 6,670 5,954
Cash at bank and in hand 50,064 22,462
56,734 28,416
Creditors: amounts falling due within one year 5 ( 14,635) ( 9,642)
Net current assets 42,099 18,774
Total assets less current liabilities 42,343 19,080
Net assets 42,343 19,080
Capital and reserves
Called-up share capital 2 2
Profit and loss account 42,341 19,078
Total shareholders' funds 42,343 19,080

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of HIJK Medical Services Limited (registered number: 14746087) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Mr N Sturt
Director

29 July 2025

HIJK MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
HIJK MEDICAL SERVICES LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

HIJK Medical Services Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 8 The Courtyard Wyncolls Road, Severalls Industrial Park, Colchester, CO4 9PE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The company's previous financial statements were prepared from incorporation on 21 March 2023 to 31 March 2024. The financial statements are therefore not entirely comparable.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Fixtures and fittings 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Income Statement as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Fixtures and fittings Total
£ £
Cost
At 01 April 2024 311 311
At 31 March 2025 311 311
Accumulated depreciation
At 01 April 2024 5 5
Charge for the financial year 62 62
At 31 March 2025 67 67
Net book value
At 31 March 2025 244 244
At 31 March 2024 306 306

4. Debtors

2025 2024
£ £
Trade debtors 2,723 964
Accrued income 3,947 4,990
6,670 5,954

5. Creditors: amounts falling due within one year

2025 2024
£ £
Amounts owed to directors 284 374
Accruals 2,016 1,920
Corporation tax 12,335 7,348
14,635 9,642

There are no amounts included above in respect of which any security has been given by the company.